Innnovation continues to be a challenge in the pharmaceutical industry,” says Dominic Behan, Ph.D., chief scientific officer and executive VP of Arena Pharmaceuticals.
“If we are going to address unmet medical needs, we must bring new innovative products to market,” he says. “The industry tends to gravitate toward lower risk targets due to the significant investment of bringing products through clinical trials and to approval. This challenge needs to be addressed by using cutting-edge technologies and expertise to access truly unique targets, and by applying innovative strategies early in the clinical trial process to assess likelihood of…
Technology Trends Impacting Pharma
Challenges Facing the Pharma Industry